2 Best APIs for Drugs in Nigeria

OpenFDA is a free, publicly accessible REST API developed by the US Food and Drug Administration (FDA) that provides access to millions of records across several critical regulatory datasets: drug adverse events, drug labeling, drug recalls, medical device adverse events, food enforcement reports, and tobacco adverse event reports. While the data originates from US regulatory submissions, OpenFDA is globally accessible and provides valuable resources for Nigerian health tech developers, pharmaceutical companies, and medical researchers who work with drugs and devices that are also sold or used in Nigeria. **What OpenFDA Does** OpenFDA exposes six primary datasets through a unified query API: **1. Drug Adverse Events (FAERS)** The FDA Adverse Event Reporting System (FAERS) contains over 20 million adverse event reports submitted by patients, healthcare professionals, and pharmaceutical companies. Each report describes a drug or biological product suspected of causing a patient's adverse outcome. Searchable by drug name, reaction type, patient demographics, and reporting date. **2. Drug Labeling** Full text of FDA-approved drug labels (package inserts) for thousands of prescription and over-the-counter drugs. Includes indications, dosage, contraindications, warnings, adverse reactions, drug interactions, and storage conditions. Updated whenever the FDA approves labeling changes. **3. Drug Recalls (Enforcement Reports)** Records of drug recall actions, including the reason for recall (contamination, mislabeling, sub-potency, etc.), the affected lot numbers, the recalling firm, and the recall classification. Searchable by drug name, NDC code, or recall date. **4. Medical Device Adverse Events (MAUDE)** Reports of problems with medical devices, including deaths, serious injuries, and malfunctions associated with specific device types and manufacturers. Important for biomedical engineers and hospital administrators monitoring device safety. **5. Food Enforcement Reports** FDA enforcement actions related to food products, including recalls of contaminated or mislabeled food items. Useful for food importers and distributors. **6. Tobacco Adverse Event Reports** Adverse event reports related to tobacco products, including electronic cigarettes. Growing relevance as vaping products enter the Nigerian market. **How Developers Use OpenFDA** No API key is required for basic usage: ``` GET https://api.fda.gov/drug/event.json?search=patient.drug.medicinalproduct:metformin&limit=10 ``` Register for a free API key at open.fda.gov to access higher rate limits (120,000 requests/day vs 1,000/day without key): ``` GET https://api.fda.gov/drug/label.json?search=brand_name:paracetamol&api_key=YOUR_KEY ``` OpenFDA uses a powerful query syntax: full-text search (`search=`), field-specific filtering, range queries for dates and numeric values, and result counting (`count=`). The `count=` parameter is particularly useful for analytics — counting adverse events by drug name, reaction type, or patient age group. **Pricing** Completely free. No payment required. The API is a public service of the US government funded by taxpayer dollars. No commercial restrictions on using the data in applications. **Rate Limits** Without API key: 240 requests/minute, 1,000 requests/day. With free API key: 240 requests/minute, 120,000 requests/day. For very high-volume data downloads, FDA also provides bulk data downloads. **Nigerian Relevance** Nigeria's pharmaceutical market includes many drugs that are also FDA-regulated — either because they are imported from the US, manufactured by US-licensed manufacturers, or are global brands with US FDA approval. Examples include common generic drugs (metformin, amoxicillin, artemether-lumefantrine, ARVs), medical devices (blood glucose meters, diagnostic equipment), and vaccines. Key use cases for Nigerian developers and organizations: 1. **Pharmacovigilance Research**: NAFDAC (National Agency for Food and Drug Administration and Control) encourages pharmacovigilance — monitoring adverse drug reactions in Nigeria. Researchers can supplement Nigerian adverse event data with FAERS reports for the same drugs to build a more complete safety picture. 2. **Drug Safety Screening**: Before importing or approving a drug batch, Nigerian pharmacists and importers can check whether the manufacturer or lot number has active FDA recalls. 3. **Clinical Decision Support**: Drug labeling data from OpenFDA can power warnings and interaction alerts in Nigerian hospital pharmacy systems, particularly for drugs used across both US and Nigerian healthcare systems. 4. **Medical Education**: Nigerian medical and pharmacy students can use OpenFDA to access original FDA drug labels as a teaching resource for pharmacology education. **Compliance Considerations** OpenFDA data is US regulatory data. It reflects FDA's jurisdiction and does not constitute NAFDAC approval or Nigerian regulatory guidance. Developers should clearly label any drug information as "US FDA Data" and direct users to NAFDAC for Nigerian regulatory decisions. OpenFDA data is in the public domain and can be freely reproduced with attribution. **Company Background** OpenFDA is developed and maintained by the US Food and Drug Administration's Office of Digital Transformation. It was launched in 2014 as part of a government initiative to make FDA's regulatory data more accessible to the public, researchers, and developers. The project is open-source on GitHub and welcomes community contributions to improve the API and documentation. OpenFDA is one of the most reliable and comprehensive pharmaceutical regulatory databases available for free — making it an invaluable resource for Nigerian health tech innovation.

RxNav is a suite of free, publicly accessible REST APIs operated by the US National Library of Medicine (NLM), part of the National Institutes of Health (NIH). RxNav provides programmatic access to several authoritative drug databases: RxNorm (the standard drug naming vocabulary), RxTerms (simplified drug terms for clinical documentation), NDF-RT (drug classification and pharmacological properties), and RxClass (drug class relationships). Together, these APIs form a comprehensive drug intelligence layer that is completely free, requires no API key, and is globally accessible — making it a foundational resource for Nigerian health tech developers building drug reference applications, clinical decision support tools, and pharmacy systems. **What RxNav Does** RxNav exposes multiple API endpoints organized around drug data needs: **1. RxNorm API** RxNorm is the US standard vocabulary for clinical drugs, providing normalized names and unique identifiers (RxCUI — RxNorm Concept Unique Identifier) for every drug. The RxNorm API allows: - **Drug lookup by name**: Search for a drug by brand name, generic name, or ingredient and receive its RxCUI - **NDC to RxNorm conversion**: Convert US National Drug Code (NDC) package codes to normalized RxNorm concepts - **Drug properties**: Get all synonyms, brand names, and generic names for a given drug concept - **Related concepts**: Navigate the drug concept hierarchy — from ingredient to clinical drug form to branded pack **2. Drug Interaction API** The most clinically critical feature: given a list of drug RxCUIs, the interaction API returns known drug-drug interactions (DDI) sourced from several interaction databases (DrugBank, ONCHigh, etc.). Returns interaction severity and description. Essential for clinical decision support. **3. RxClass API** Drug classification by multiple taxonomies: - Pharmacological class (mechanism of action, physiological effect, chemical structure) - Drug class hierarchies (EPC class, VA class, ATC class, MESH) - Allows lookup of all drugs in a class, or the classes a specific drug belongs to **4. RxTerms API** Simplified drug terms for prescribing interfaces — shows how a drug would appear in a clinical dropdown, e.g., "Metformin 500 MG Oral Tablet" in a standardized, concise format. **5. Spelling Suggestions** Given a misspelled drug name, returns likely intended drug names — useful for search interfaces in clinical apps where users may misspell drug names. **How Developers Use RxNav** No API key required. Direct REST calls: Drug lookup: ``` GET https://rxnav.nlm.nih.gov/REST/drugs.json?name=metformin ``` Drug interactions for a list of RxCUI codes: ``` GET https://rxnav.nlm.nih.gov/REST/interaction/list.json?rxcuis=207106+152923 ``` All drugs in a class: ``` GET https://rxnav.nlm.nih.gov/REST/rxclass/classMembers.json?classId=N0000175743&relaSource=FDASPL ``` Responses are JSON (or XML if specified). The API is RESTful, stateless, and well-documented at rxnav.nlm.nih.gov. **Pricing and Rate Limits** Completely free. Operated as a public service by the US government. No API key required. No documented hard rate limits for normal usage — but extremely aggressive automated scraping should be avoided as a courtesy. **Nigerian Relevance** RxNav's drug databases are US-centric (based on US NDC codes and FDA-approved drug names), but their utility for Nigerian health tech is significant because: 1. Most drugs used in Nigeria are manufactured by global pharmaceutical companies with US FDA approvals. The active ingredients (metformin, artemether, lopinavir, amoxicillin, chloroquine, etc.) have RxNorm entries regardless of the country of use. 2. Drug interaction data is pharmacological — the interaction between metformin and contrast agents is the same in Nigeria as in the US. RxNav's interaction database provides globally applicable clinical warnings. 3. Nigerian medical students and pharmacists study pharmacology using international references (BNF, Goodman & Gilman) that align with RxNorm's drug classification. RxClass provides programmatic access to the same classification frameworks. **Drug Interaction Checking for Nigerian Hospitals** Polypharmacy (patients taking multiple medications simultaneously) is a significant safety concern in Nigerian hospitals. A Nigerian hospital's prescribing system can integrate RxNav's interaction API to: 1. When a doctor adds a new drug to a patient's prescription, look up the RxCUI for the new drug and all current medications 2. Query the interaction API with all drug RxCUIs 3. Display any identified interactions with severity rating and description 4. Require the doctor to acknowledge or override the warning before finalizing the prescription This is a potentially life-saving feature that can be implemented at near-zero cost using RxNav. **Generic Drug Substitution** In Nigeria's cost-sensitive healthcare market, patients and pharmacists frequently need to find affordable generic alternatives to expensive branded drugs. RxNav's concept relationship data allows building a brand-to-generic lookup: given a brand name (e.g., "Glucophage"), retrieve the ingredient (metformin), then list all drug products containing that ingredient as generics. **Compliance Considerations** RxNav data is US drug data. Drug names, dosages, and approvals may differ between US and Nigerian regulatory contexts. Applications should clearly indicate data source and direct users to NAFDAC for Nigeria-specific drug registration status. RxNav data is public domain and freely usable in any application. **Company Background** RxNav is developed and maintained by the Lister Hill National Center for Biomedical Communications, a research center within the US National Library of Medicine (NLM), part of the National Institutes of Health (NIH). NLM is the world's largest biomedical library and operates numerous free public APIs including PubMed, ClinicalTrials.gov, and MedlinePlus. RxNav has been publicly available since 2009 and is widely used in health IT systems globally. RxNav is one of the most valuable free drug data APIs available for health tech developers anywhere in the world, including Nigeria.